Tuberculosis Diagnostics and Treatment Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tuberculosis Diagnostics and Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Skin Testing
1.2.3 Laboratory Testing
1.3 Market by Application
1.3.1 Global Tuberculosis Diagnostics and Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis Diagnostics and Treatment Market Perspective (2017-2028)
2.2 Tuberculosis Diagnostics and Treatment Growth Trends by Region
2.2.1 Tuberculosis Diagnostics and Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Tuberculosis Diagnostics and Treatment Historic Market Size by Region (2017-2022)
2.2.3 Tuberculosis Diagnostics and Treatment Forecasted Market Size by Region (2023-2028)
2.3 Tuberculosis Diagnostics and Treatment Market Dynamics
2.3.1 Tuberculosis Diagnostics and Treatment Industry Trends
2.3.2 Tuberculosis Diagnostics and Treatment Market Drivers
2.3.3 Tuberculosis Diagnostics and Treatment Market Challenges
2.3.4 Tuberculosis Diagnostics and Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tuberculosis Diagnostics and Treatment Players by Revenue
3.1.1 Global Top Tuberculosis Diagnostics and Treatment Players by Revenue (2017-2022)
3.1.2 Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Tuberculosis Diagnostics and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tuberculosis Diagnostics and Treatment Revenue
3.4 Global Tuberculosis Diagnostics and Treatment Market Concentration Ratio
3.4.1 Global Tuberculosis Diagnostics and Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis Diagnostics and Treatment Revenue in 2021
3.5 Tuberculosis Diagnostics and Treatment Key Players Head office and Area Served
3.6 Key Players Tuberculosis Diagnostics and Treatment Product Solution and Service
3.7 Date of Enter into Tuberculosis Diagnostics and Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tuberculosis Diagnostics and Treatment Breakdown Data by Type
4.1 Global Tuberculosis Diagnostics and Treatment Historic Market Size by Type (2017-2022)
4.2 Global Tuberculosis Diagnostics and Treatment Forecasted Market Size by Type (2023-2028)
5 Tuberculosis Diagnostics and Treatment Breakdown Data by Application
5.1 Global Tuberculosis Diagnostics and Treatment Historic Market Size by Application (2017-2022)
5.2 Global Tuberculosis Diagnostics and Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Tuberculosis Diagnostics and Treatment Market Size (2017-2028)
6.2 North America Tuberculosis Diagnostics and Treatment Market Size by Type
6.2.1 North America Tuberculosis Diagnostics and Treatment Market Size by Type (2017-2022)
6.2.2 North America Tuberculosis Diagnostics and Treatment Market Size by Type (2023-2028)
6.2.3 North America Tuberculosis Diagnostics and Treatment Market Share by Type (2017-2028)
6.3 North America Tuberculosis Diagnostics and Treatment Market Size by Application
6.3.1 North America Tuberculosis Diagnostics and Treatment Market Size by Application (2017-2022)
6.3.2 North America Tuberculosis Diagnostics and Treatment Market Size by Application (2023-2028)
6.3.3 North America Tuberculosis Diagnostics and Treatment Market Share by Application (2017-2028)
6.4 North America Tuberculosis Diagnostics and Treatment Market Size by Country
6.4.1 North America Tuberculosis Diagnostics and Treatment Market Size by Country (2017-2022)
6.4.2 North America Tuberculosis Diagnostics and Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Tuberculosis Diagnostics and Treatment Market Size (2017-2028)
7.2 Europe Tuberculosis Diagnostics and Treatment Market Size by Type
7.2.1 Europe Tuberculosis Diagnostics and Treatment Market Size by Type (2017-2022)
7.2.2 Europe Tuberculosis Diagnostics and Treatment Market Size by Type (2023-2028)
7.2.3 Europe Tuberculosis Diagnostics and Treatment Market Share by Type (2017-2028)
7.3 Europe Tuberculosis Diagnostics and Treatment Market Size by Application
7.3.1 Europe Tuberculosis Diagnostics and Treatment Market Size by Application (2017-2022)
7.3.2 Europe Tuberculosis Diagnostics and Treatment Market Size by Application (2023-2028)
7.3.3 Europe Tuberculosis Diagnostics and Treatment Market Share by Application (2017-2028)
7.4 Europe Tuberculosis Diagnostics and Treatment Market Size by Country
7.4.1 Europe Tuberculosis Diagnostics and Treatment Market Size by Country (2017-2022)
7.4.2 Europe Tuberculosis Diagnostics and Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size (2017-2028)
8.2 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Type
8.2.1 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Application
8.3.1 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Region
8.4.1 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Tuberculosis Diagnostics and Treatment Market Size (2017-2028)
9.2 Latin America Tuberculosis Diagnostics and Treatment Market Size by Type
9.2.1 Latin America Tuberculosis Diagnostics and Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Tuberculosis Diagnostics and Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Tuberculosis Diagnostics and Treatment Market Share by Type (2017-2028)
9.3 Latin America Tuberculosis Diagnostics and Treatment Market Size by Application
9.3.1 Latin America Tuberculosis Diagnostics and Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Tuberculosis Diagnostics and Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Tuberculosis Diagnostics and Treatment Market Share by Application (2017-2028)
9.4 Latin America Tuberculosis Diagnostics and Treatment Market Size by Country
9.4.1 Latin America Tuberculosis Diagnostics and Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Tuberculosis Diagnostics and Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size (2017-2028)
10.2 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Type
10.2.1 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Application
10.3.1 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Country
10.4.1 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Cepheid Inc
11.1.1 Cepheid Inc Company Details
11.1.2 Cepheid Inc Business Overview
11.1.3 Cepheid Inc Tuberculosis Diagnostics and Treatment Introduction
11.1.4 Cepheid Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022)
11.1.5 Cepheid Inc Recent Developments
11.2 Becton Dickinson
11.2.1 Becton Dickinson Company Details
11.2.2 Becton Dickinson Business Overview
11.2.3 Becton Dickinson Tuberculosis Diagnostics and Treatment Introduction
11.2.4 Becton Dickinson Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022)
11.2.5 Becton Dickinson Recent Developments
11.3 Hain LifeSciences
11.3.1 Hain LifeSciences Company Details
11.3.2 Hain LifeSciences Business Overview
11.3.3 Hain LifeSciences Tuberculosis Diagnostics and Treatment Introduction
11.3.4 Hain LifeSciences Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022)
11.3.5 Hain LifeSciences Recent Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Tuberculosis Diagnostics and Treatment Introduction
11.4.4 Abbott Laboratories Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022)
11.4.5 Abbott Laboratories Recent Developments
11.5 Alere, Inc
11.5.1 Alere, Inc Company Details
11.5.2 Alere, Inc Business Overview
11.5.3 Alere, Inc Tuberculosis Diagnostics and Treatment Introduction
11.5.4 Alere, Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022)
11.5.5 Alere, Inc Recent Developments
11.6 Roche AG
11.6.1 Roche AG Company Details
11.6.2 Roche AG Business Overview
11.6.3 Roche AG Tuberculosis Diagnostics and Treatment Introduction
11.6.4 Roche AG Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022)
11.6.5 Roche AG Recent Developments
11.7 Hologic Corporation
11.7.1 Hologic Corporation Company Details
11.7.2 Hologic Corporation Business Overview
11.7.3 Hologic Corporation Tuberculosis Diagnostics and Treatment Introduction
11.7.4 Hologic Corporation Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022)
11.7.5 Hologic Corporation Recent Developments
11.8 bioMerieux
11.8.1 bioMerieux Company Details
11.8.2 bioMerieux Business Overview
11.8.3 bioMerieux Tuberculosis Diagnostics and Treatment Introduction
11.8.4 bioMerieux Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022)
11.8.5 bioMerieux Recent Developments
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Tuberculosis Diagnostics and Treatment Introduction
11.9.4 Sanofi Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022)
11.9.5 Sanofi Recent Developments
11.10 QIAGEN
11.10.1 QIAGEN Company Details
11.10.2 QIAGEN Business Overview
11.10.3 QIAGEN Tuberculosis Diagnostics and Treatment Introduction
11.10.4 QIAGEN Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022)
11.10.5 QIAGEN Recent Developments
11.11 Akonni Biosystems, Inc.
11.11.1 Akonni Biosystems, Inc. Company Details
11.11.2 Akonni Biosystems, Inc. Business Overview
11.11.3 Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Introduction
11.11.4 Akonni Biosystems, Inc. Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022)
11.11.5 Akonni Biosystems, Inc. Recent Developments
11.12 Epistem Holdings Plc
11.12.1 Epistem Holdings Plc Company Details
11.12.2 Epistem Holdings Plc Business Overview
11.12.3 Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Introduction
11.12.4 Epistem Holdings Plc Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022)
11.12.5 Epistem Holdings Plc Recent Developments
11.13 Gen-Probe Inc.
11.13.1 Gen-Probe Inc. Company Details
11.13.2 Gen-Probe Inc. Business Overview
11.13.3 Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Introduction
11.13.4 Gen-Probe Inc. Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022)
11.13.5 Gen-Probe Inc. Recent Developments
11.14 EIKEN Chemical
11.14.1 EIKEN Chemical Company Details
11.14.2 EIKEN Chemical Business Overview
11.14.3 EIKEN Chemical Tuberculosis Diagnostics and Treatment Introduction
11.14.4 EIKEN Chemical Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022)
11.14.5 EIKEN Chemical Recent Developments
11.15 Thermo Fisher Scientific, Inc
11.15.1 Thermo Fisher Scientific, Inc Company Details
11.15.2 Thermo Fisher Scientific, Inc Business Overview
11.15.3 Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Introduction
11.15.4 Thermo Fisher Scientific, Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022)
11.15.5 Thermo Fisher Scientific, Inc Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Tuberculosis Diagnostics and Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Skin Testing
Table 3. Key Players of Laboratory Testing
Table 4. Global Tuberculosis Diagnostics and Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Tuberculosis Diagnostics and Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Tuberculosis Diagnostics and Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Tuberculosis Diagnostics and Treatment Market Share by Region (2017-2022)
Table 8. Global Tuberculosis Diagnostics and Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Tuberculosis Diagnostics and Treatment Market Share by Region (2023-2028)
Table 10. Tuberculosis Diagnostics and Treatment Market Trends
Table 11. Tuberculosis Diagnostics and Treatment Market Drivers
Table 12. Tuberculosis Diagnostics and Treatment Market Challenges
Table 13. Tuberculosis Diagnostics and Treatment Market Restraints
Table 14. Global Tuberculosis Diagnostics and Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Tuberculosis Diagnostics and Treatment Revenue Share by Players (2017-2022)
Table 16. Global Top Tuberculosis Diagnostics and Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Diagnostics and Treatment as of 2021)
Table 17. Ranking of Global Top Tuberculosis Diagnostics and Treatment Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Tuberculosis Diagnostics and Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Tuberculosis Diagnostics and Treatment Product Solution and Service
Table 21. Date of Enter into Tuberculosis Diagnostics and Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Tuberculosis Diagnostics and Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Type (2017-2022)
Table 25. Global Tuberculosis Diagnostics and Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Type (2023-2028)
Table 27. Global Tuberculosis Diagnostics and Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Tuberculosis Diagnostics and Treatment Revenue Share by Application (2017-2022)
Table 29. Global Tuberculosis Diagnostics and Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Tuberculosis Diagnostics and Treatment Revenue Share by Application (2023-2028)
Table 31. North America Tuberculosis Diagnostics and Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Tuberculosis Diagnostics and Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Tuberculosis Diagnostics and Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Tuberculosis Diagnostics and Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Tuberculosis Diagnostics and Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Tuberculosis Diagnostics and Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Tuberculosis Diagnostics and Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Tuberculosis Diagnostics and Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Tuberculosis Diagnostics and Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Tuberculosis Diagnostics and Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Tuberculosis Diagnostics and Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Tuberculosis Diagnostics and Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Tuberculosis Diagnostics and Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Tuberculosis Diagnostics and Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Tuberculosis Diagnostics and Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Tuberculosis Diagnostics and Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Tuberculosis Diagnostics and Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Tuberculosis Diagnostics and Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Tuberculosis Diagnostics and Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Tuberculosis Diagnostics and Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Tuberculosis Diagnostics and Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Tuberculosis Diagnostics and Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Tuberculosis Diagnostics and Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Tuberculosis Diagnostics and Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Tuberculosis Diagnostics and Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Tuberculosis Diagnostics and Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Tuberculosis Diagnostics and Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Tuberculosis Diagnostics and Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Tuberculosis Diagnostics and Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Tuberculosis Diagnostics and Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 61. Cepheid Inc Company Details
Table 62. Cepheid Inc Business Overview
Table 63. Cepheid Inc Tuberculosis Diagnostics and Treatment Product
Table 64. Cepheid Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022) & (US$ Million)
Table 65. Cepheid Inc Recent Developments
Table 66. Becton Dickinson Company Details
Table 67. Becton Dickinson Business Overview
Table 68. Becton Dickinson Tuberculosis Diagnostics and Treatment Product
Table 69. Becton Dickinson Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022) & (US$ Million)
Table 70. Becton Dickinson Recent Developments
Table 71. Hain LifeSciences Company Details
Table 72. Hain LifeSciences Business Overview
Table 73. Hain LifeSciences Tuberculosis Diagnostics and Treatment Product
Table 74. Hain LifeSciences Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022) & (US$ Million)
Table 75. Hain LifeSciences Recent Developments
Table 76. Abbott Laboratories Company Details
Table 77. Abbott Laboratories Business Overview
Table 78. Abbott Laboratories Tuberculosis Diagnostics and Treatment Product
Table 79. Abbott Laboratories Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022) & (US$ Million)
Table 80. Abbott Laboratories Recent Developments
Table 81. Alere, Inc Company Details
Table 82. Alere, Inc Business Overview
Table 83. Alere, Inc Tuberculosis Diagnostics and Treatment Product
Table 84. Alere, Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022) & (US$ Million)
Table 85. Alere, Inc Recent Developments
Table 86. Roche AG Company Details
Table 87. Roche AG Business Overview
Table 88. Roche AG Tuberculosis Diagnostics and Treatment Product
Table 89. Roche AG Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022) & (US$ Million)
Table 90. Roche AG Recent Developments
Table 91. Hologic Corporation Company Details
Table 92. Hologic Corporation Business Overview
Table 93. Hologic Corporation Tuberculosis Diagnostics and Treatment Product
Table 94. Hologic Corporation Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022) & (US$ Million)
Table 95. Hologic Corporation Recent Developments
Table 96. bioMerieux Company Details
Table 97. bioMerieux Business Overview
Table 98. bioMerieux Tuberculosis Diagnostics and Treatment Product
Table 99. bioMerieux Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022) & (US$ Million)
Table 100. bioMerieux Recent Developments
Table 101. Sanofi Company Details
Table 102. Sanofi Business Overview
Table 103. Sanofi Tuberculosis Diagnostics and Treatment Product
Table 104. Sanofi Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022) & (US$ Million)
Table 105. Sanofi Recent Developments
Table 106. QIAGEN Company Details
Table 107. QIAGEN Business Overview
Table 108. QIAGEN Tuberculosis Diagnostics and Treatment Product
Table 109. QIAGEN Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022) & (US$ Million)
Table 110. QIAGEN Recent Developments
Table 111. Akonni Biosystems, Inc. Company Details
Table 112. Akonni Biosystems, Inc. Business Overview
Table 113. Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Product
Table 114. Akonni Biosystems, Inc. Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022) & (US$ Million)
Table 115. Akonni Biosystems, Inc. Recent Developments
Table 116. Epistem Holdings Plc Company Details
Table 117. Epistem Holdings Plc Business Overview
Table 118. Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Product
Table 119. Epistem Holdings Plc Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022) & (US$ Million)
Table 120. Epistem Holdings Plc Recent Developments
Table 121. Gen-Probe Inc. Company Details
Table 122. Gen-Probe Inc. Business Overview
Table 123. Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Product
Table 124. Gen-Probe Inc. Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022) & (US$ Million)
Table 125. Gen-Probe Inc. Recent Developments
Table 126. EIKEN Chemical Company Details
Table 127. EIKEN Chemical Business Overview
Table 128. EIKEN Chemical Tuberculosis Diagnostics and Treatment Product
Table 129. EIKEN Chemical Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022) & (US$ Million)
Table 130. EIKEN Chemical Recent Developments
Table 131. Thermo Fisher Scientific, Inc Company Details
Table 132. Thermo Fisher Scientific, Inc Business Overview
Table 133. Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Product
Table 134. Thermo Fisher Scientific, Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2017-2022) & (US$ Million)
Table 135. Thermo Fisher Scientific, Inc Recent Developments
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tuberculosis Diagnostics and Treatment Market Share by Type: 2021 VS 2028
Figure 2. Skin Testing Features
Figure 3. Laboratory Testing Features
Figure 4. Global Tuberculosis Diagnostics and Treatment Market Share by Application: 2021 VS 2028
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. Tuberculosis Diagnostics and Treatment Report Years Considered
Figure 9. Global Tuberculosis Diagnostics and Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Tuberculosis Diagnostics and Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Tuberculosis Diagnostics and Treatment Market Share by Region: 2021 VS 2028
Figure 12. Global Tuberculosis Diagnostics and Treatment Market Share by Players in 2021
Figure 13. Global Top Tuberculosis Diagnostics and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Diagnostics and Treatment as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Tuberculosis Diagnostics and Treatment Revenue in 2021
Figure 15. North America Tuberculosis Diagnostics and Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Tuberculosis Diagnostics and Treatment Market Size Market Share by Type (2017-2028)
Figure 17. North America Tuberculosis Diagnostics and Treatment Market Size Market Share by Application (2017-2028)
Figure 18. North America Tuberculosis Diagnostics and Treatment Market Size Share by Country (2017-2028)
Figure 19. United States Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Tuberculosis Diagnostics and Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Tuberculosis Diagnostics and Treatment Market Size Market Share by Type (2017-2028)
Figure 23. Europe Tuberculosis Diagnostics and Treatment Market Size Market Share by Application (2017-2028)
Figure 24. Europe Tuberculosis Diagnostics and Treatment Market Size Share by Country (2017-2028)
Figure 25. Germany Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Tuberculosis Diagnostics and Treatment Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Tuberculosis Diagnostics and Treatment Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Tuberculosis Diagnostics and Treatment Market Size Share by Region (2017-2028)
Figure 35. China Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Tuberculosis Diagnostics and Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Tuberculosis Diagnostics and Treatment Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Tuberculosis Diagnostics and Treatment Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Tuberculosis Diagnostics and Treatment Market Size Share by Country (2017-2028)
Figure 45. Mexico Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Tuberculosis Diagnostics and Treatment Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Tuberculosis Diagnostics and Treatment Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Tuberculosis Diagnostics and Treatment Market Size Share by Country (2017-2028)
Figure 51. Turkey Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Cepheid Inc Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2017-2022)
Figure 55. Becton Dickinson Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2017-2022)
Figure 56. Hain LifeSciences Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2017-2022)
Figure 57. Abbott Laboratories Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2017-2022)
Figure 58. Alere, Inc Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2017-2022)
Figure 59. Roche AG Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2017-2022)
Figure 60. Hologic Corporation Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2017-2022)
Figure 61. bioMerieux Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2017-2022)
Figure 62. Sanofi Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2017-2022)
Figure 63. QIAGEN Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2017-2022)
Figure 64. Akonni Biosystems, Inc. Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2017-2022)
Figure 65. Epistem Holdings Plc Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2017-2022)
Figure 66. Gen-Probe Inc. Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2017-2022)
Figure 67. EIKEN Chemical Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2017-2022)
Figure 68. Thermo Fisher Scientific, Inc Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2017-2022)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Industry Market Size
